|
1OHP
|
DNA damage
|
---|
| |
Averaged counts
|
AST
|
---|
Exposed
| | | |
CYP1A1 (MspI)b w1/w1
|
2.37 ± 0.29*
|
5.08 ± 2.45*
|
11.23 ± 0.92*
|
w1/m1 + m1/m1
|
3.33 ± 0.71*
|
5.81 ± 0.43
|
13.13 ± 1.65*
|
CYP1A1 (Ile/Val)c w2/w2
|
2.71 ± 0.31*
|
5.22 ± 0.22*
|
11.51 ± 0.84*
|
w2/m2 + m2/m2
|
1.96 ± 0.61*
|
5.85 ± 0.75
|
13.91 ± 2.95
|
EPHX
d Low
|
2.17 ± 0.37*,§
|
5.22 ± 0.30
|
12.63 ± 1.12*
|
Medium + High
|
3.19 ± 0.45*
|
5.00 ± 0.30*
|
10.72 ± 1.16*
|
GSTM1 Active
|
2.53 ± 0.38*
|
5.46 ± 0.29*
|
12.14 ± 1,09*
|
Null
|
2.79 ± 0.45*
|
5.05 ± 0.32
|
11.22 ± 1,21*
|
Controls
| | | |
CYP1A1 (MspI)b w1/w1
|
0.14 ± 0.02
|
4.28 ± 0.25
|
7.24 ± 1.10
|
w1/m1 + m1/m1
|
0.21 ± 0.05
|
4.87 ± 0.53
|
6.54 ± 1.30
|
CYP1A1 (Ile/Val)c w2/w2
|
0.14 ± 0.02
|
4.38 ± 0.24
|
6.77 ± 0.91
|
w2/m2 + m2/m2
|
0.20 ± 0.07
|
4.25 ± 0.30
|
10.86 ± 5.08
|
EPHX
d Low
|
0.13 ± 0.02
|
4.58 ± 0.33
|
7.34 ± 1.13
|
Medium + High
|
0.16 ± 0.02
|
4.21 ± 0.30
|
6.96 ± 1.43
|
GSTM1 Active
|
0.15 ± 0.02
|
4.49 ± 0.32
|
8.32 ± 1,48
|
Null
|
0.15 ± 0.03
|
4.23 ± 0.31
|
5.67 ± 1,02
|
-
a, b, c, d See notes in Table 2.
- * p < 0.05, exposed vs. controls; § p < 0.05, EPHX Low vs. EPHX Medium + High. Non-parametric Mann-Whitney U-test.